
PF-05150122
CAS No. 1235406-03-7
PF-05150122( PF05150122 )
Catalog No. M10944 CAS No. 1235406-03-7
PF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 272 | Get Quote |
![]() ![]() |
10MG | 408 | Get Quote |
![]() ![]() |
25MG | 672 | Get Quote |
![]() ![]() |
50MG | 945 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePF-05150122
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM.
-
DescriptionPF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM, no significant activity against Nav1.5.Pain Phase 1 Discontinued.
-
In VitroPF-05186462 inhibits human Nav1.7 channels (IC50=21 nM) in HEK293 cells.PF-05186462 exhibits a high plasma protein binding rate.
-
In Vivo——
-
SynonymsPF05150122
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number1235406-03-7
-
Formula Weight531.885
-
Molecular FormulaC19H10ClF4N5O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name5-chloro-2-fluoro-4-(2-(pyridazin-4-yl)-4-(trifluoromethyl)phenoxy)-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Swain NA, et al. J Med Chem. 2017 Aug 24;60(16):7029-7042.
2. Jones HM, et al. Clin Pharmacokinet. 2016 Jul;55(7):875-87.
molnova catalog



related products
-
ABBV-318
ABBV-318 can be used as small molecule Nav1.7/Nav1.8 blockers for the treatment of pain, with IC50 values of 2.8 μM for hNav1.7 and 3.8 μM for hNav1.8. ABBV-318 can be used to study pain-related disorders.
-
Eleclazine hydrochlo...
A novel, potent, and selective inhibitor of Late sodium current (late INa) for treatment of long QT-3 syndrome (LQT-3).
-
Amiloride hydrochlor...
A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.